| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1063-4584(03)00052-9 |
| P698 | PubMed publication ID | 12801482 |
| P2093 | author name string | S A Jimenez | |
| G R Dodge | |||
| P2860 | cites work | Structure of the human aggrecan gene: exon-intron organization and association with the protein domains | Q24528200 |
| Glucosamine for osteoarthritis: magic, hype, or confusion? It's probably safe-but there's no good evidence that it works | Q28366848 | ||
| Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis | Q28374250 | ||
| The hexosamine pathway regulates the plasminogen activator inhibitor-1 gene promoter and Sp1 transcriptional activation through protein kinase C-beta I and -delta | Q28577643 | ||
| Effects of an orally administered mixture of chondroitin sulfate, glucosamine hydrochloride and manganese ascorbate on synovial fluid chondroitin sulfate 3B3 and 7D4 epitope in a canine cruciate ligament transection model of osteoarthritis | Q31938498 | ||
| Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial | Q32050561 | ||
| Interleukin-1beta down-regulates the expression of glucuronosyltransferase I, a key enzyme priming glycosaminoglycan biosynthesis: influence of glucosamine on interleukin-1beta-mediated effects in rat chondrocytes | Q32067938 | ||
| Activation of the proteolytic activity of ADAMTS4 (aggrecanase-1) by C-terminal truncation | Q34109859 | ||
| A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee | Q34122293 | ||
| Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro. | Q34503637 | ||
| Glucosamine sulfate modulates dysregulated activities of human osteoarthritic chondrocytes in vitro | Q34508733 | ||
| Preferential incorporation of glucosamine into the galactosamine moieties of chondroitin sulfates in articular cartilage explants | Q34515154 | ||
| Glucosamine modulates IL-1-induced activation of rat chondrocytes at a receptor level, and by inhibiting the NF-kappa B pathway | Q34520479 | ||
| Chondrocyte-mediated catabolism of aggrecan: aggrecanase-dependent cleavage induced by interleukin-1 or retinoic acid can be inhibited by glucosamine | Q34752761 | ||
| Hexosamine-induced fibronectin protein synthesis in mesangial cells is associated with increases in cAMP responsive element binding (CREB) phosphorylation and nuclear CREB: the involvement of protein kinases A and C. | Q38296491 | ||
| Glucosamine HCl reduces equine articular cartilage degradation in explant culture | Q42490895 | ||
| Flux through the hexosamine pathway is a determinant of nuclear factor kappaB- dependent promoter activation | Q43935477 | ||
| A simple, rapid, and sensitive DNA assay procedure | Q56879279 | ||
| Formation of nodular structures resembling mature articular cartilage in long–term primary cultures of human fetal epiphyseal chondrocytes on a hydrogel substrate | Q61771891 | ||
| In vivo chondroprotection and metabolic synergy of glucosamine and chondroitin sulfate | Q73322078 | ||
| Mannosamine inhibits aggrecanase-mediated changes in the physical properties and biochemical composition of articular cartilage | Q73367599 | ||
| Characterization of human type II procollagen and collagen-specific antibodies and their application to the study of human type II collagen processing and ultrastructure | Q73410885 | ||
| Effects of interleukin-1beta and tumor necrosis factor-alpha on expression of matrix-related genes by cultured equine articular chondrocytes | Q73887889 | ||
| Glucosamine activates the plasminogen activator inhibitor 1 gene promoter through Sp1 DNA binding sites in glomerular mesangial cells | Q74034155 | ||
| Chondrocyte-mediated catabolism of aggrecan: evidence for a glycosylphosphatidylinositol-linked protein in the aggrecanase response to interleukin-1 or retinoic acid | Q77967633 | ||
| P433 | issue | 6 | |
| P921 | main subject | osteoarthritis | Q62736 |
| glucosamine | Q32907954 | ||
| P304 | page(s) | 424-432 | |
| P577 | publication date | 2003-06-01 | |
| P1433 | published in | Osteoarthritis and Cartilage | Q7107605 |
| P1476 | title | Glucosamine sulfate modulates the levels of aggrecan and matrix metalloproteinase-3 synthesized by cultured human osteoarthritis articular chondrocytes | |
| P478 | volume | 11 |
| Q33678954 | 10mM glucosamine prevents activation of proADAMTS5 (aggrecanase-2) in transfected cells by interference with post-translational modification of furin |
| Q47624228 | A novel glucosamine derivative with low cytotoxicity enhances chondrogenic differentiation of ATDC5. |
| Q33873693 | A peptidyl-glucosamine derivative affects IKKalpha kinase activity in human chondrocytes |
| Q46602405 | Additive effects of glucosamine or risedronate for the treatment of osteoarthritis of the knee combined with home exercise: a prospective randomized 18-month trial |
| Q47270462 | Antiarthritic activity of a standardized, multiherbal, Ayurvedic formulation containing Boswellia serrata: in vitro studies on knee cartilage from osteoarthritis patients. |
| Q35666160 | Biological basis for the benefit of nutraceutical supplementation in arthritis |
| Q34545778 | Carbohydrate engineered cells for regenerative medicine. |
| Q46112675 | Chondrocyte proliferation in a new culture system. |
| Q22000858 | Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: a basic science study |
| Q36862703 | Chondroprotective Potential of Fruit Extracts of Phyllanthus emblica in Osteoarthritis |
| Q36309644 | Chondroprotective drugs in degenerative joint diseases |
| Q46702331 | Chondroprotective effects of glucosamine involving the p38 MAPK and Akt signaling pathways |
| Q80160722 | Chondroprotective potential of root extracts of Withania somnifera in osteoarthritis |
| Q33632751 | Comparison of glucose derivatives effects on cartilage degradation |
| Q24630640 | Crystalline glucosamine sulfate in the management of knee osteoarthritis: efficacy, safety, and pharmacokinetic properties |
| Q38697367 | Description of d-glucosamine immobilization kinetics onto poly(lactic acid) surface via a multistep physicochemical approach for preparation of novel active biomaterials. |
| Q43076770 | Dietary glucosamine under question |
| Q34001775 | Effect of chondroitin sulphate in symptomatic knee osteoarthritis: a multicentre, randomised, double-blind, placebo-controlled study |
| Q36432339 | Effect of fucoidan extracted from mozuku on experimental cartilaginous tissue injury |
| Q35147261 | Effects of Glucosamine and Chondroitin Sulfate on Cartilage Metabolism in OA: Outlook on Other Nutrient Partners Especially Omega-3 Fatty Acids |
| Q54493171 | Effects of glucosamine administration on patients with rheumatoid arthritis. |
| Q46960081 | Effects of intra-articular administration of glucosamine and a peptidyl-glucosamine derivative in a rabbit model of experimental osteoarthritis: a pilot study |
| Q57813369 | Evaluation of structural, mechanical, and cellular behavior of electrospun poly-3-hydroxybutyrate scaffolds loaded with glucosamine sulfate to develop cartilage tissue engineering |
| Q57957374 | Five percent oxygen tension is not beneficial for neocartilage formation in scaffold-free cell cultures |
| Q38362244 | Glucosamine Hydrochloride but Not Chondroitin Sulfate Prevents Cartilage Degradation and Inflammation Induced by Interleukin-1α in Bovine Cartilage Explants |
| Q40070187 | Glucosamine affects intracellular signalling through inhibition of mitogen-activated protein kinase phosphorylation in human chondrocytes. |
| Q42330053 | Glucosamine and chondroitin for the treatment of osteoarthritis |
| Q41176136 | Glucosamine exposure reduces proteoglycan synthesis in primary human endothelial cells in vitro |
| Q33368886 | Glucosamine increases hyaluronic acid production in human osteoarthritic synovium explants |
| Q22000860 | Glucosamine prevents in vitro collagen degradation in chondrocytes by inhibiting advanced lipoxidation reactions and protein oxidation |
| Q55072302 | Glucosamine protects nucleus pulposus cells and induces autophagy via the mTOR-dependent pathway. |
| Q37960179 | Glucosamine therapy for knee osteoarthritis: pharmacokinetic considerations |
| Q36918156 | Glucosamine: an ingredient with skin and other benefits |
| Q46313679 | High levels of glucosamine-chondroitin sulfate can alter the cyclic preload and acute overload responses of chondral explants |
| Q37754703 | Inflammation and arthritis: perspectives of the glycobiologist |
| Q43700545 | Intra-articular delivery of glucosamine for treatment of experimental osteoarthritis created by a medial meniscectomy in a rat model. |
| Q35636751 | Low levels of human serum glucosamine after ingestion of glucosamine sulphate relative to capability for peripheral effectiveness |
| Q36374283 | Medical treatment of osteoarthritis in the horse - a review |
| Q34978132 | New Frontiers for Cartilage Repair and Protection |
| Q46106832 | Non-surgical treatment of osteoarthritis of large joints - new aspects |
| Q36209436 | Nutraceutical therapies for degenerative joint diseases: a critical review. |
| Q36182261 | Pharmaceutical and nutraceutical management of canine osteoarthritis: present and future perspectives. |
| Q34636799 | Physiological effects of oral glucosamine on joint health: current status and consensus on future research priorities |
| Q90723642 | Proinflammatory Effects of IL-1β Combined with IL-17A Promoted Cartilage Degradation and Suppressed Genes Associated with Cartilage Matrix Synthesis In Vitro |
| Q82496709 | Remodeling of the notochord during development of vertebral fusions in Atlantic salmon (Salmo salar) |
| Q47151673 | Scientific Opinion on the substantiation of a health claim related to glucosamine and maintenance of normal joint cartilage pursuant to Article 13(5) of Regulation (EC) No 1924/2006 |
| Q33275599 | Selection of reliable reference genes for qPCR studies on chondroprotective action |
| Q39746558 | Synergistic chondroprotective effect of alpha-tocopherol, ascorbic acid, and selenium as well as glucosamine and chondroitin on oxidant induced cell death and inhibition of matrix metalloproteinase-3--studies in cultured chondrocytes. |
| Q52644417 | Synovial Fluid Eotaxin-1 Levels May Reflect Disease Progression in Primary Knee Osteoarthritis Among Elderly Han Chinese: A Cross-Sectional Study. |
| Q41966032 | The Fate of Oral Glucosamine Traced by (13)C Labeling in the Dog. |
| Q90183180 | The N-Acetyl Phenylalanine Glucosamine Derivative Attenuates the Inflammatory/Catabolic Environment in a Chondrocyte-Synoviocyte Co-Culture System |
| Q46838762 | The catabolic effect of TNFα on bovine nucleus pulposus intervertebral disc cells and the restraining role of glucosamine sulfate in the TNFα-mediated up-regulation of MMP-3. |
| Q34369140 | The effects of three-month oral supplementation with a nutraceutical and exercise on the locomotor pattern of aged horses |
| Q37667284 | The efficacy and tolerability of glucosamine sulfate in the treatment of knee osteoarthritis: A randomized, double-blind, placebo-controlled trial |
| Q36719696 | The reverse glucosamine sulfate pathway: application in knee osteoarthritis |
| Q35624596 | The use of glucosamine therapy in osteoarthritis |
| Q45127723 | The use of glucosamine therapy in osteoarthritis |
Search more.